Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michał Nicze"'
Autor:
Michał Nicze, Adrianna Dec, Maciej Borówka, Damian Krzyżak, Aleksandra Bołdys, Łukasz Bułdak, Bogusław Okopień
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8202 (2024)
Obesity is a chronic disease caused primarily by the imbalance between the amount of calories supplied to the body and energy expenditure. Not only does it deteriorate the quality of life, but most importantly it increases the risk of cardiovascular
Externí odkaz:
https://doaj.org/article/90fe9c09b1524f32b0313142bd8493f3
Autor:
Michał Nicze, Maciej Borówka, Adrianna Dec, Aleksandra Niemiec, Łukasz Bułdak, Bogusław Okopień
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 815 (2024)
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majori
Externí odkaz:
https://doaj.org/article/cfe73c202c8440c6a78171f1efb59727
Publikováno v:
Cancers, Vol 14, Iss 17, p 4086 (2022)
Modern oncological therapy utilizes various types of immunotherapy. Immune checkpoint inhibitors (ICIs), chimeric antigen receptor T cells (CAR-T) therapy, cancer vaccines, tumor-targeting monoclonal antibodies (TT-mAbs), bispecific antibodies and cy
Externí odkaz:
https://doaj.org/article/7b8e8820fca8410a81f988480aa8b36d
Autor:
Kinga Wyżgolik, Kamil Wdowiak, Stanisław Łącki, Jerzy Chudek, Sylwia Georgiew-Nadziakiewicz, Michał Nicze
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal antibody, which may affect the clinical course of novel corona